Another study showed that NLRX1 deletion in colitis mice drives changes in gut–microbiome interactions exacerbating disease; however, restoration of WT glutamine metabolic profiles via glutamine supplementation abrogated effects in microbiome, inflammation and disease severity [58]. This evidence concerns the gene NLRX1 and colitis.